Renalytix PLC 2025 Annual Report
Company: Renalytix PLC
Sector: Healthcare & social services
Country: United States
Year: 2025
Type: Annual Report
Pages: 94
The report describes FY2025 as a year of commercial expansion, with testing volumes up 37% and total revenues up 30%. The company maintained Medicare reimbursement and advanced partnerships with MVP Health Care and Tempus AI to widen patient and provider access. Group revenue was $3.0 million, comprising $2.7 million of testing services and $0.3 million of pharmaceutical services. Its CSR disclosure commits to minimizing environmental effects, while the report says annual emissions and energy quantities were not practical to calculate.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.